Skip to content

Agrify Corporation RYM Nonlicensing Revenue — Revenue

Other product segments

License
$9.98M+413%

Similar metrics at other companies

Under Armour logo
UAALicense revenues — Revenue
$26.85M+10.9%
WEY
WEYSLicense — Revenue
$886K-10.3%
BioCryst Pharmaceuticals logo
BCRXLicense and other revenues — Total revenues
$5.01M+187%
Ardelyx logo
ARDXLicensing revenue — Total revenues
$51K-99.0%
SoundHound AI, Inc. logo
SOUNLicensing — Revenue
$7.68M+101%
Rhythm Pharmaceuticals, Inc. logo
RYTMLicense revenue — Total revenues
$0+100%

Other financials

Income statement

See full
Revenue$13.3M+2,370%
Gross profit$10.4M+11,452%
Operating income-$4.0M-9.0%
Net income$19.9M+1,325%
EPS (diluted)$1.33+260%

Balance sheet

See full
Cash & equivalents$33.3M+36.0%
Total debt$89.2M+695%
Total equity$36.6M+36.4%
Total assets$127.5M+180%

Cash flow

See full
Operating cash flow$1.0M+116%
CapEx$2.0K+100%
Free cash flow-$1.8M+15.5%

Valuation

See full
Market cap$54.76M+33.2%
Enterprise value$110.74M+43.4%
P/S1.8×

Profitability

See full
Gross margin68.3%
Operating margin-108.8%
Net margin-39%
FCF margin-244.9%+1,014pp

Returns & leverage

See full
Return on equity-36.9%
Debt / equity2.4×+2.0×
Current ratio0.5×-1.0×

Where this comes from

Reported directly by Agrify Corporation in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Agrify Corporation’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agrify Corporation's nonlicensing revenue — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agrify Corporation's nonlicensing revenue — revenue?
Agrify Corporation (RYM) reported nonlicensing revenue — revenue of $3.31M in Q1 2026.
How has Agrify Corporation's nonlicensing revenue — revenue changed year-over-year?
Agrify Corporation's nonlicensing revenue — revenue increased by 515.4% year-over-year, from $538K to $3.31M.
What does nonlicensing revenue — revenue mean?
This metric represents the total gross revenue generated from the company's non-licensing business activities, specifically excluding income derived from intellectual property or technology licensing agreements. It reflects the direct sales performance of products or services, such as consumer goods or cultivation solutions, within the company's operational portfolio. Monitoring this figure helps investors assess the scale and growth trajectory of the company's core commercial operations independent of royalty-based income streams.